nav-left cat-right
cat-right

3rd annual Peptides event on July 6-7 2016, in Lon...

In recent years, therapeutic peptides have been developed for the treatment of several diseases such as cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders, among others. As a result of their efficacy treating a huge array of conditions, further research has been done to develop a rich pipeline of novel peptides. SMi’s 3rd annual Peptides event provides the perfect platform to discuss the...

11th EFMC Short Course on Medicinal Chemistry Engi...

This intensive course is intended for scientists with interests in the field of peptide and protein engineering covering topics around synthetic peptides, engineered proteins and therapeutic antibodies. The number of participants will be limited to 35 to assure the possibility for in-depth discussions. The presentations and tutorials will be given by academic and industrial experts and will cover broad historical perspectives...

10th EFMC Short Course on Medicinal Chemistry Apri...

In 2009, EFMC launched a series of short courses aimed to favour cultural and scientific growth of the medicinal chemistry community and organized with affordable fees for participation. EFMC will continue the tradition in 2015, and is pleased to announce the following courses: 10th EFMC Short Course on Medicinal Chemistry Small-Molecule Modulation of Protein-Protein Interactions (PPIs) Oegstgeest (near Leiden), The...

3rd Immunogenicity and Immunotoxicity Conference o...

The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and...

Possible treatment for kidney disease in lupus

In the U.S. alone, more than 1.5 million people have lupus, a chronic autoimmune disease in which the immune system turns against itself, attacking a person’s healthy tissue, cells and organs. The symptoms can range from debilitating pain and fatigue to organ failure. Dr. Chandra Mohan, a biomedical engineer at the University of Houston (UH), has a theory about the development of lupus nephritis and, if he’s...

Adaptor protein role in diabetes, cancer treatment...

A protein known to be part of a complex communications network within the cell has also been found to be associated with important processes involved in cancer and diabetes. In a study that will be published Feb. 18 in Science Signaling, researchers identified a new role for the adaptor protein p66Shc in controlling glucose metabolism and cell growth, two processes that are highly regulated in our cells. When disruptions in...
Page 1 of 3123